This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

P3 Prostate Cancer Forum 2025 Register your interest

Register your interest in attending the P3 2025 meeting

P3 background - Article

This is a promotional meeting which is being organised and funded by Bayer.

The meeting will include mention of product.

The P3 Prostate Cancer Forum will take place in London in May 2025. If you are interested in attending, please provide the information below to receive priority access to registration to this event.

Registration to attend the meeting will be available mid-January 2025.

P3 Prostate Cancer Forum: 2024
perspectives, possibilities, progress
PP-NUB-GB-2012, January 2025
NUBEQA® (darolutamide)
In nmCRPC
PP-NUB-GB-2321, April 2025

PP-NUB-GB-1919, October 2024